Organogenesis Holdings
ORGO
146 hedge funds and large institutions have $283M invested in Organogenesis Holdings in 2022 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 56 increasing their positions, 47 reducing their positions, and 28 closing their positions.
23% more call options, than puts
Call options by funds: $226K | Put options by funds: $183K
19% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 47
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 44.96% → 44.95% (-0.01%)
6% less funds holding
Funds holding: 156 → 146 (-10)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
36% less capital invested
Capital invested by funds: $441M → $283M (-$158M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$16.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$10.8M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$9.61M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.83M |
| 5 |
Morgan Stanley
New York
|
+$3.17M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$24.7M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$6.09M |
| 3 |
Millennium Management
New York
|
-$5.27M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$3.38M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$2.99M |
ORGO Hedge Fund Activity: Q2 2022 in Review
146 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q2 2022, worth a combined $283M — down 36% from $441M a quarter earlier.
Sellers outnumbered buyers: 28 funds closed out of ORGO and 22 opened new positions — a net loss of 6 holders — while 47 trimmed existing stakes and 56 added.
The largest buyer was Soleus Capital Management, adding an estimated $16.9M. The largest seller was Deerfield Management, cutting an estimated $24.7M.
- 146 institutional investors held Organogenesis Holdings (ORGO) as of Q2 2022, down from 156 in Q1 2022.
- Funds reported $283M of Organogenesis Holdings stock for Q2 2022, down 36% quarter-over-quarter.
- 22 funds opened new Organogenesis Holdings positions in Q2 2022 and 28 closed out, a net change of -6 holders.
- The largest Organogenesis Holdings buyer in Q2 2022 was Soleus Capital Management, an estimated $16.9M added.
- The largest Organogenesis Holdings seller in Q2 2022 was Deerfield Management, an estimated $24.7M sold.
Based on aggregated 13F filings for Q2 2022.